Suppr超能文献

姜黄素及其类似物去甲氧基姜黄素对顺铂耐药卵巢癌细胞中miR-133b及其靶基因GSTP-1的影响

Effects of Curcumin and Its Analogue Desmethoxycurcumin on miR-133b and Its Target Gene GSTP-1 in Cisplatin-resistant Ovarian Cancer Cells.

作者信息

Ülker Esin Bayrali, Aktaş Esin Çetin, Seyhan Mehmet Fatih, Isbir Turgay, Billur Deryanaz, Timirci-Kahraman Özlem

机构信息

Department of Molecular Medicine, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkiye.

Department of Molecular Medicine, Institute of Graduate Studies in Health Sciences, Istanbul University, Istanbul, Turkiye.

出版信息

Anticancer Res. 2024 Dec;44(12):5351-5359. doi: 10.21873/anticanres.17362.

Abstract

BACKGROUND/AIM: Ovarian cancer, despite being the fifth most common gynecological malignancy, has the highest mortality rate. Recent clinical studies have explored the potential of natural products, like curcumin (CUR), to enhance conventional chemotherapy by targeting multiple cellular pathways. This study aimed to evaluate the effects of CUR and its analog, demethoxycurcumin (DMC), on human ovarian cancer and cisplatin-resistant ovarian cancer cell proliferation and apoptosis. Additionally, we investigated the expression of a candidate gene (GSTP-1), and microRNA (miR-133b) involvement in glutathione metabolism, a potential resistance mechanism in cisplatin-resistant ovarian cancer cells.

MATERIALS AND METHODS

Cell proliferation was measured using the WST-1 assay after exposing cisplatin-resistant (A2780cp) and sensitive (A2780) ovarian cancer cell lines to various concentrations of CUR and DMC for different time periods. Apoptosis was quantified using the Annexin V-FITC/PI assay. To understand the underlying mechanisms, we examined the expression levels of GSTP-1 and miR-133b using quantitative RT-PCR.

RESULTS

The WST-1 assay revealed that CUR and DMC inhibited cell proliferation in both cell lines, with cisplatin causing a sharper viability decline in A2780cp cells. Annexin V-PI staining detected early apoptosis induced by CUR, DMC, and their combinations in both cell lines at 12 hours, with no necrosis observed. Gene expression analysis showed a significant decrease in GSTP-1 and miR-133b levels in A2780cp cells compared to A2780 cells. The combination treatments, particularly Cur+DMC+Cisplatin, synergistically reduced GSTP-1 and miR-133b expression.

CONCLUSION

This study demonstrated the potential of CUR and DMC to enhance the efficacy of cisplatin in ovarian cancer treatment. The observed decrease in GSTP-1 and miR-133b expression in cisplatin-resistant cells suggests their involvement in drug resistance and highlights their potential as therapeutic targets.

摘要

背景/目的:卵巢癌虽是第五大常见妇科恶性肿瘤,但其死亡率最高。近期临床研究探索了天然产物如姜黄素(CUR)通过靶向多种细胞途径增强传统化疗的潜力。本研究旨在评估CUR及其类似物去甲氧基姜黄素(DMC)对人卵巢癌和顺铂耐药性卵巢癌细胞增殖及凋亡的影响。此外,我们研究了一个候选基因(GSTP - 1)的表达以及参与谷胱甘肽代谢的微小RNA(miR - 133b),谷胱甘肽代谢是顺铂耐药性卵巢癌细胞中的一种潜在耐药机制。

材料与方法

将顺铂耐药(A2780cp)和敏感(A2780)卵巢癌细胞系暴露于不同浓度的CUR和DMC不同时间段后,使用WST - 1法检测细胞增殖。采用Annexin V - FITC/PI法对凋亡进行定量分析。为了解潜在机制,我们使用定量逆转录聚合酶链反应检测GSTP - 1和miR - 133b的表达水平。

结果

WST - 1检测显示,CUR和DMC均抑制两种细胞系的细胞增殖,顺铂使A2780cp细胞的活力下降更明显。Annexin V - PI染色检测到CUR、DMC及其组合在12小时时诱导两种细胞系发生早期凋亡,未观察到坏死现象。基因表达分析显示,与A2780细胞相比,A2780cp细胞中GSTP - 1和miR - 133b水平显著降低。联合治疗,尤其是Cur + DMC + 顺铂,协同降低了GSTP - 1和miR - 133b的表达。

结论

本研究证明了CUR和DMC在增强顺铂治疗卵巢癌疗效方面的潜力。在顺铂耐药细胞中观察到的GSTP - 1和miR - 133b表达降低表明它们参与耐药过程,并突出了它们作为治疗靶点的潜力。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验